Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Broad Center for Mendelian Genomics, |
RCV001005012 | SCV001164574 | pathogenic | Leber congenital amaurosis 6 | 2018-12-03 | criteria provided, single submitter | research | The heterozygous c.1468-263G>C variant in RPGRIP1 was identified by our study, in the compound heterozygous state, along with a likely pathogenic variant, in one individual with Leber congenital amaurosis (PMID: 30072743). The c.1468-263G>C variant in RPGRIP1 has not been previously reported in individuals with Leber congenital amaurosis and was absent from large population studies. In vitro functional studies provide some evidence that the c.1468-263G>C variant may impact protein function by activating an in-frame cryptic splice site. The resulting transcript will include a premature stop codon and is predicted to lead to a truncated or absent protein (PMID: 30072743). However, these types of assays may not accurately represent biological function. Computational tools do support an impact to splicing. Loss of function of the RPGRIP1 gene is an established disease mechanism in autosomal recessive Leber congenital amaurosis. The presence of this variant in combination with a reported likely pathogenic variant and in an individual with Leber congenital amaurosis increases the likelihood that the c.1468-263G>C variant is pathogenic. In summary, this variant meets criteria to be classified as pathogenic for Leber congenital amaurosis in an autosomal recessive manner based on the predicted impact of the protein functional evidence. ACMG/AMP Criteria applied: PM2, PVS1, PS3, PM3_Supporting (Richards 2015). |